Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs placebo for obsession symptoms in bipolar mood disorder
IRCT2014092719295N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) and obsessive compulsive disorder (OCD) comparing Aripiprazole with Placebo (2 arms). Started May 2016; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar disorder (BD)obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2014092719295N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014092719295N1.